Should angiotensin converting enzyme (ACE) inhibitors be used routinely after infarction? Perspectives from the Survival and Ventricular Enlargement (SAVE) trial.
Sutton
M S
MS
Royal Brompton, National Heart and Lung Hospital, London.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000517:prevention & control; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000517:prevention & control*; D009206:Myocardium / Q000473:pathology; D015912:Thrombolytic Therapy
D000806:Angiotensin-Converting Enzyme Inhibitors